Thromboembolic Events Associated with Bevacizumab plus Chemotherapy for Patients with Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Bevacizumab is a recombinant, humanized monoclonal antibody that hinders the proliferation of new blood vessels required for malignant progression. The drug is considered safe and tolerable; however, some controversy remains about whether it is linked to venous and arterial thromboemboli...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Am Health Drug Benefits
Hoofdauteurs: Alahmari, Abdullah K., Almalki, Ziyad S., Alahmari, Ahmed K., Guo, Jeff J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Engage Healthcare Communications, LLC 2016
Onderwerpen:
Clinical
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5004819/
https://ncbi.nlm.nih.gov/pubmed/27688834
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items